{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/15/3311621/0/en/Context-Therapeutics-Announces-Positive-Interim-Efficacy-and-Safety-Results-from-Ongoing-Phase-1-Clinical-Trial-for-CTIM-76.html", "message": "News view counter 798672 successfully enlarged"}